Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants, particularly those with multiple mutations in receptor‐binding domain (RBD), pose a critical challenge to the efficacy of coronavirus disease 2019 (COVID‐19) vaccines and therapeutic neutralizing monoclonal antibodies (mAbs)....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qianqian, Zhang, Mengyi, Liang, Ziteng, Zhang, Li, Wu, Xi, Yang, Chaoying, An, Yimeng, Tong, Jincheng, Liu, Shuo, Li, Tao, Cui, Qianqian, Nie, Jianhui, Wu, Jiajing, Huang, Weijin, Wang, Youchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994617/
https://www.ncbi.nlm.nih.gov/pubmed/35434713
http://dx.doi.org/10.1002/mco2.130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994617/
https://www.ncbi.nlm.nih.gov/pubmed/35434713
http://dx.doi.org/10.1002/mco2.130

Ejemplares similares